These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34558155)

  • 1. Current findings and perspectives on aberrant neural oscillations in schizophrenia.
    Hirano Y; Uhlhaas PJ
    Psychiatry Clin Neurosci; 2021 Dec; 75(12):358-368. PubMed ID: 34558155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a neurodynamical understanding of the prodrome in schizophrenia.
    Mikanmaa E; Grent-'t-Jong T; Hua L; Recasens M; Thune H; Uhlhaas PJ
    Neuroimage; 2019 Apr; 190():144-153. PubMed ID: 29175199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia.
    Uhlhaas PJ; Haenschel C; Nikolić D; Singer W
    Schizophr Bull; 2008 Sep; 34(5):927-43. PubMed ID: 18562344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oscillations and neuronal dynamics in schizophrenia: the search for basic symptoms and translational opportunities.
    Uhlhaas PJ; Singer W
    Biol Psychiatry; 2015 Jun; 77(12):1001-9. PubMed ID: 25676489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent topics in neurophysiological studies of patients with schizophrenia].
    Onitsuka T
    Seishin Shinkeigaku Zasshi; 2013; 115(8):847-52. PubMed ID: 24167965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring alterations in oscillatory brain networks in schizophrenia with resting-state MEG: State-of-the-art and methodological challenges.
    Alamian G; Hincapié AS; Pascarella A; Thiery T; Combrisson E; Saive AL; Martel V; Althukov D; Haesebaert F; Jerbi K
    Clin Neurophysiol; 2017 Sep; 128(9):1719-1736. PubMed ID: 28756348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of α5 GABAA receptor agonists in the treatment of cognitive deficits in schizophrenia.
    Gill KM; Grace AA
    Curr Pharm Des; 2014; 20(31):5069-76. PubMed ID: 24345268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired GABAergic neurotransmission in schizophrenia underlies impairments in cortical gamma band oscillations.
    McNally JM; McCarley RW; Brown RE
    Curr Psychiatry Rep; 2013 Mar; 15(3):346. PubMed ID: 23400808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural oscillations as a translational tool in schizophrenia research: rationale, paradigms and challenges.
    Phillips KG; Uhlhaas PJ
    J Psychopharmacol; 2015 Feb; 29(2):155-68. PubMed ID: 25567552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities.
    McNally JM; McCarley RW
    Curr Opin Psychiatry; 2016 May; 29(3):202-10. PubMed ID: 26900672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High vs low frequency neural oscillations in schizophrenia.
    Moran LV; Hong LE
    Schizophr Bull; 2011 Jul; 37(4):659-63. PubMed ID: 21653278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEG-measured visually induced gamma-band oscillations in chronic schizophrenia: Evidence for impaired generation of rhythmic activity in ventral stream regions.
    Grent-'t-Jong T; Rivolta D; Sauer A; Grube M; Singer W; Wibral M; Uhlhaas PJ
    Schizophr Res; 2016 Oct; 176(2-3):177-185. PubMed ID: 27349815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oscillatory, Computational, and Behavioral Evidence for Impaired GABAergic Inhibition in Schizophrenia.
    Shaw AD; Knight L; Freeman TCA; Williams GM; Moran RJ; Friston KJ; Walters JTR; Singh KD
    Schizophr Bull; 2020 Feb; 46(2):345-353. PubMed ID: 31219602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using joint ICA to link function and structure using MEG and DTI in schizophrenia.
    Stephen JM; Coffman BA; Jung RE; Bustillo JR; Aine CJ; Calhoun VD
    Neuroimage; 2013 Dec; 83():418-30. PubMed ID: 23777757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEG resting-state oscillations and their relationship to clinical symptoms in schizophrenia.
    Zeev-Wolf M; Levy J; Jahshan C; Peled A; Levkovitz Y; Grinshpoon A; Goldstein A
    Neuroimage Clin; 2018; 20():753-761. PubMed ID: 30238919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting-state theta-band connectivity and verbal memory in schizophrenia and in the high-risk state.
    Andreou C; Leicht G; Nolte G; Polomac N; Moritz S; Karow A; Hanganu-Opatz IL; Engel AK; Mulert C
    Schizophr Res; 2015 Feb; 161(2-3):299-307. PubMed ID: 25553979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new look at gamma? High- (>60 Hz) γ-band activity in cortical networks: function, mechanisms and impairment.
    Uhlhaas PJ; Pipa G; Neuenschwander S; Wibral M; Singer W
    Prog Biophys Mol Biol; 2011 Mar; 105(1-2):14-28. PubMed ID: 21034768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia.
    Gonzalez-Burgos G; Fish KN; Lewis DA
    Neural Plast; 2011; 2011():723184. PubMed ID: 21904685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia.
    Sun L; Castellanos N; Grützner C; Koethe D; Rivolta D; Wibral M; Kranaster L; Singer W; Leweke MF; Uhlhaas PJ
    Schizophr Res; 2013 Nov; 150(2-3):519-25. PubMed ID: 24016727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.
    Sumiyoshi T; Bubenikova-Valesova V; Horacek J; Bert B
    Adv Ther; 2008 Oct; 25(10):1037-56. PubMed ID: 18839076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.